Keyphrases
Disease Severity
100%
Bronchiectasis
100%
Antimicrobial Peptides
100%
Disease Exacerbation
100%
Secretory Leukocyte Protease Inhibitor
75%
LL-37
62%
Sputum
50%
Future Risk
25%
Pseudomonas Aeruginosa Infection
25%
Exacerbation Rate
25%
Frequent Exacerbator
25%
Microbes
12%
Host Defense
12%
Lysozyme
12%
Severe Disease
12%
Dysregulated
12%
Dysregulation
12%
Forced Expiratory Volume in 1 Second (FEV1)
12%
European Centre
12%
Airway
12%
Peptide Release
12%
Biological Mechanisms
12%
Chronic Lung Disease
12%
Bronchiectasis Severity Index
12%
Severity Risk
12%
Exacerbation Risk
12%
Local Antimicrobials
12%
Lactoferrin
12%
Cathelicidin LL-37
12%
Medicine and Dentistry
Disease Exacerbation
100%
Disease Severity
100%
Bronchiectasis
100%
Polypeptide Antibiotic Agent
100%
Secretory Leukocyte Protease Inhibitor
75%
Sputum
50%
Pseudomonas Infection
25%
Enzyme Linked Immunosorbent Assay
12%
Forced Expiratory Volume
12%
Chronic Lung Disease
12%
Host Resistance
12%
Lactoferrin
12%
Cathelicidin Antimicrobial Peptide LL 37
12%
Lysozyme
12%
Diseases
12%
Immunology and Microbiology
Antimicrobial Peptides
100%
Leukocyte
75%
Sputum
50%
Pseudomonas aeruginosa
25%
Host Resistance
12%
ELISA
12%
Forced Expiratory Volume
12%
Microorganism
12%
Lysozyme
12%
Airway
12%
Cathelicidin
12%
Biochemistry, Genetics and Molecular Biology
Antimicrobial Peptides
100%
Secretory Leukocyte Protease Inhibitor
75%
Pseudomonas aeruginosa
25%
Host Resistance
12%
Forced Expiratory Volume
12%
Microorganism
12%
Lysozyme
12%
Lactoferrin
12%
Cathelicidin
12%